Thrombin Inhibits the Migration of Human Liver Myofibroblasts
Identifieur interne : 000533 ( France/Analysis ); précédent : 000532; suivant : 000534Thrombin Inhibits the Migration of Human Liver Myofibroblasts
Auteurs : J. Gillibert-Duplantier [France] ; V. Neaud [France] ; A. Desmoulière [France] ; P. Bioulac-Sage [France] ; J. Rosenbaum [France]Source :
- Wound Repair and Regeneration [ 1067-1927 ] ; 2005-01.
Abstract
Liver myofibroblasts are the key cells of liver fibrogenesis. Recent data show that the serine proteinase thrombin is involved in fibrogenesis through a mitogenic effect on myofibroblasts. The aim of this study was to evaluate the effects of thrombin on the migration of human liver myofibroblasts; another major parameter in fibrogenesis. In a Boyden chamber assay, thrombin dose‐dependently (10−10–10−7 M) decreased spontaneous myofibroblast migration down to 49 ± 1% of control values (p = 5.10−10) without affecting cell adhesion or viability. Thrombin effect was blocked by its specific catalytic inhibitor hirudin and could be reproduced by using the proteinase‐activated receptor‐1 (PAR‐1) agonist SFLLRNP. Thrombin also completely inhibited migration when induced by the chemotactic agent platelet‐derived growth factor‐BB. We then investigated the signaling mechanisms involved. The COX‐2 inhibitor NS398 dose‐dependently (2.5–10 μM) blunted the inhibitory effect of thrombin on spontaneous migration. However, NS398 did not reverse the inhibitory effect of thrombin on PDGF‐BB‐induced migration. Phosphatidylinositol 3‐kinase (PI3‐K) is a major determinant of chemotaxis induced by PDGF. Whereas thrombin did not itself induce PI3‐K activity, as shown by the lack of detectable phosphorylation of Akt‐1, it inhibited PDGF‐BB‐induced Akt‐1 phosphorylation. This effect was dependent of the Rho/ROCK pathway since it was abolished in the presence of the ROCK inhibitor Y‐27632. In summary, thrombin, acting via a proteinase‐activated receptor, inhibits human liver myofibroblasts migration. Inhibition of basal migration is dependent on COX‐2, while inhibition of PDGF‐BB‐induced migration involves decreased PI3‐K activation via a Rho/ROCK mechanism. We suggest that thrombin could thus stabilize activated myofibroblasts on the site of active fibrogenesis.
Url:
DOI: 10.1111/j.1067-1927.2005.130117j.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 004444
- to stream Istex, to step Curation: 004444
- to stream Istex, to step Checkpoint: 001873
- to stream Main, to step Merge: 008320
- to stream Main, to step Curation: 008097
- to stream Main, to step Exploration: 008097
- to stream France, to step Extraction: 000533
Links to Exploration step
ISTEX:9108CE187D09E7FB1B34C5534B0D7C0B35E9B989Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Thrombin Inhibits the Migration of Human Liver Myofibroblasts</title><author><name sortKey="Gillibert Uplantier, J" sort="Gillibert Uplantier, J" uniqKey="Gillibert Uplantier J" first="J" last="Gillibert-Duplantier">J. Gillibert-Duplantier</name></author><author><name sortKey="Neaud, V" sort="Neaud, V" uniqKey="Neaud V" first="V" last="Neaud">V. Neaud</name></author><author><name sortKey="Desmouliere, A" sort="Desmouliere, A" uniqKey="Desmouliere A" first="A" last="Desmoulière">A. Desmoulière</name></author><author><name sortKey="Bioulac Age, P" sort="Bioulac Age, P" uniqKey="Bioulac Age P" first="P" last="Bioulac-Sage">P. Bioulac-Sage</name></author><author><name sortKey="Rosenbaum, J" sort="Rosenbaum, J" uniqKey="Rosenbaum J" first="J" last="Rosenbaum">J. Rosenbaum</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:9108CE187D09E7FB1B34C5534B0D7C0B35E9B989</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1111/j.1067-1927.2005.130117j.x</idno><idno type="url">https://api.istex.fr/document/9108CE187D09E7FB1B34C5534B0D7C0B35E9B989/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004444</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">004444</idno><idno type="wicri:Area/Istex/Curation">004444</idno><idno type="wicri:Area/Istex/Checkpoint">001873</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001873</idno><idno type="wicri:doubleKey">1067-1927:2005:Gillibert Uplantier J:thrombin:inhibits:the</idno><idno type="wicri:Area/Main/Merge">008320</idno><idno type="wicri:Area/Main/Curation">008097</idno><idno type="wicri:Area/Main/Exploration">008097</idno><idno type="wicri:Area/France/Extraction">000533</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Thrombin Inhibits the Migration of Human Liver Myofibroblasts</title><author><name sortKey="Gillibert Uplantier, J" sort="Gillibert Uplantier, J" uniqKey="Gillibert Uplantier J" first="J" last="Gillibert-Duplantier">J. Gillibert-Duplantier</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>GREF, INSERM E0362, Université Victor Segalen Bordeaux 2, Bordeaux</wicri:regionArea><placeName><region type="region">Nouvelle-Aquitaine</region><region type="old region">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="Neaud, V" sort="Neaud, V" uniqKey="Neaud V" first="V" last="Neaud">V. Neaud</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>GREF, INSERM E0362, Université Victor Segalen Bordeaux 2, Bordeaux</wicri:regionArea><placeName><region type="region">Nouvelle-Aquitaine</region><region type="old region">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="Desmouliere, A" sort="Desmouliere, A" uniqKey="Desmouliere A" first="A" last="Desmoulière">A. Desmoulière</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>GREF, INSERM E0362, Université Victor Segalen Bordeaux 2, Bordeaux</wicri:regionArea><placeName><region type="region">Nouvelle-Aquitaine</region><region type="old region">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="Bioulac Age, P" sort="Bioulac Age, P" uniqKey="Bioulac Age P" first="P" last="Bioulac-Sage">P. Bioulac-Sage</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>GREF, INSERM E0362, Université Victor Segalen Bordeaux 2, Bordeaux</wicri:regionArea><placeName><region type="region">Nouvelle-Aquitaine</region><region type="old region">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="Rosenbaum, J" sort="Rosenbaum, J" uniqKey="Rosenbaum J" first="J" last="Rosenbaum">J. Rosenbaum</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>GREF, INSERM E0362, Université Victor Segalen Bordeaux 2, Bordeaux</wicri:regionArea><placeName><region type="region">Nouvelle-Aquitaine</region><region type="old region">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Wound Repair and Regeneration</title><title level="j" type="alt">WOUND REPAIR REGENERATION</title><idno type="ISSN">1067-1927</idno><idno type="eISSN">1524-475X</idno><imprint><biblScope unit="vol">13</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="A19">A19</biblScope><biblScope unit="page" to="A19">A19</biblScope><biblScope unit="page-count">1</biblScope><publisher>Blackwell Science Inc</publisher><pubPlace>Oxford, UK; Malden, USA</pubPlace><date type="published" when="2005-01">2005-01</date></imprint><idno type="ISSN">1067-1927</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1067-1927</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Liver myofibroblasts are the key cells of liver fibrogenesis. Recent data show that the serine proteinase thrombin is involved in fibrogenesis through a mitogenic effect on myofibroblasts. The aim of this study was to evaluate the effects of thrombin on the migration of human liver myofibroblasts; another major parameter in fibrogenesis. In a Boyden chamber assay, thrombin dose‐dependently (10−10–10−7 M) decreased spontaneous myofibroblast migration down to 49 ± 1% of control values (p = 5.10−10) without affecting cell adhesion or viability. Thrombin effect was blocked by its specific catalytic inhibitor hirudin and could be reproduced by using the proteinase‐activated receptor‐1 (PAR‐1) agonist SFLLRNP. Thrombin also completely inhibited migration when induced by the chemotactic agent platelet‐derived growth factor‐BB. We then investigated the signaling mechanisms involved. The COX‐2 inhibitor NS398 dose‐dependently (2.5–10 μM) blunted the inhibitory effect of thrombin on spontaneous migration. However, NS398 did not reverse the inhibitory effect of thrombin on PDGF‐BB‐induced migration. Phosphatidylinositol 3‐kinase (PI3‐K) is a major determinant of chemotaxis induced by PDGF. Whereas thrombin did not itself induce PI3‐K activity, as shown by the lack of detectable phosphorylation of Akt‐1, it inhibited PDGF‐BB‐induced Akt‐1 phosphorylation. This effect was dependent of the Rho/ROCK pathway since it was abolished in the presence of the ROCK inhibitor Y‐27632. In summary, thrombin, acting via a proteinase‐activated receptor, inhibits human liver myofibroblasts migration. Inhibition of basal migration is dependent on COX‐2, while inhibition of PDGF‐BB‐induced migration involves decreased PI3‐K activation via a Rho/ROCK mechanism. We suggest that thrombin could thus stabilize activated myofibroblasts on the site of active fibrogenesis.</div></front></TEI><affiliations><list><country><li>France</li></country><region><li>Aquitaine</li><li>Nouvelle-Aquitaine</li></region><settlement><li>Bordeaux</li></settlement></list><tree><country name="France"><region name="Nouvelle-Aquitaine"><name sortKey="Gillibert Uplantier, J" sort="Gillibert Uplantier, J" uniqKey="Gillibert Uplantier J" first="J" last="Gillibert-Duplantier">J. Gillibert-Duplantier</name></region><name sortKey="Bioulac Age, P" sort="Bioulac Age, P" uniqKey="Bioulac Age P" first="P" last="Bioulac-Sage">P. Bioulac-Sage</name><name sortKey="Desmouliere, A" sort="Desmouliere, A" uniqKey="Desmouliere A" first="A" last="Desmoulière">A. Desmoulière</name><name sortKey="Neaud, V" sort="Neaud, V" uniqKey="Neaud V" first="V" last="Neaud">V. Neaud</name><name sortKey="Rosenbaum, J" sort="Rosenbaum, J" uniqKey="Rosenbaum J" first="J" last="Rosenbaum">J. Rosenbaum</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000533 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000533 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= France
|étape= Analysis
|type= RBID
|clé= ISTEX:9108CE187D09E7FB1B34C5534B0D7C0B35E9B989
|texte= Thrombin Inhibits the Migration of Human Liver Myofibroblasts
}}
| This area was generated with Dilib version V0.6.31. |  |